Astatine-211-labeled BC8-B10 monoclonal antibody

BC8-B10 monoclonal antibody labeled with Astatine-211 · Fred Hutchinson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Astatine-211-labeled BC8-B10 monoclonal antibody, covering 2025-12-18 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases [Phase 1, Phase 2]

See pricing